Abstract
The complexity of the immune response is only beginning to unfold. It is becoming clear that a subtle and certainly complex interaction with exogenous events and internal dysregulation leads to the expression of intra-ocular inflammatory disease. In this short review an attempt is made to evaluate three areas. The first is the initiation of the immune response, with particular attention to the role of HLA and the environment. This is followed by the mechanisms that lead to disease expression, and the third area is the practitioner's attempt to exogenously manipulate these immune events in order to treat the patient.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Benacerraf B, Green I, Paul WE. The immune response of guinea pigs to hapten-poly-L-lysine conjugates as an example of the genetic control of the recognition of antigenicity. Cold Spring Harbor Symp Quant Biol 1967; 32: 569–75.
Brewerton DA, Hart FD, Nicholls A, et al. Ankylosing spondylitis and HL-A27. Lancet 1973; i: 904.
Nussenblatt RB, Mittal KK, Ryan S, Maumenee AE. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol 1982; 94: 147–58.
Coppin H, McDevitt HO. Absence of polymorphism between HLA-B27 genomic exon sequences isolated from normal donors and ankylosing spondylitis patients. J Immunol 1986; 137: 2168–78.
Sela O, El-Roeiy A, senberg DA, et al. A common antiDNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheumatism 1987; 30: 50–6.
Geczy AF, Alexander K, Bashir HV, Edmonds JP, Upfold L, Sullivan J. HLA-B27, Klebsiella and ankylosing spondylitis: Biological and chemical studies. Immunological Rev 1983; 70: 23–50.
Bottazzo GF, Pujol-Borrell R, Hanafusa T, et al. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; ii: 1115–9.
Dernouchamps JP, Vaerman JP, Michiels J, et al. Immune complexes in the aqueous humor and serum. Am J Ophthalmol 1977; 84: 24–31.
Rosenbaum JT, McDewitt HO, Guss RB, et al. Nature 1980; 286: 611–3.
Kim MK, Chan CC, Nussenblatt RB, et al. Pharmacologic effects on the expression of class II histocompatibility antigen in experimental endotoxin-induced uveitis. Clin Immunol Immunopath 1987; 45: 70–7.
Beckingsale AB, Williams D, Gibson JM, et al. Klebsiella and acute anterior uveitis. Br J Ophthalmol 1984; 68: 866–8.
Elschnig A. Studien zur sympathischen Ophthalmis. Die antigene Wirkung des Augenpigmentes. Albrecht von Graefes Arch ophthalmol 1910; 76: 509–46.
Wacker WB, Donoso LA, Kalsow CM, et al. Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol 1977; 119: 1949–58.
Faure JP. Autoimmunity and the retina. Curr Top Eye Res 1980; 2: 215–302.
Wiggert B, Chader GJ. Monkey interphotoreceptor retinoid-binding protein (IRBP): Isolation, characterization, and synthesis. In Bridges CD, Adler AJ, eds. The Interphotoreceptor Matrix in Health and Disease. New York: Alan R. Liss, 1985: 89–110.
Nussenblatt RB, Kuwabara T, de Monasterio FM, Wacker WB. S-antigen uveitis in primates. A new model for human disease. Arch Ophthalmol 1981; 99: 1090–2.
Salinas-Carmona MC, Nussenblatt RB, Gery I. Experimental autoimmune uveitis in the athymic nude rat. Eur J Immunol 1982; 25: 481–4.
Rozenszajn LA, Muellenberg-Coulombre C, Gery I, et al. Induction of experimental autoimmune uveoretinitis (EAU) in rats by T-cell lines. Immunology 1986; 57: 559–65.
Caspi RR, Roberge FG, McAllister CG, et al. T-cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol 1986; 136: 928–33.
Nussenblatt RB, Palestine AG, El-Saied, et al. Long-term antigen specific and non-specific T-cell lines and clones in uveitis. Curr Eye Res 1984; 3: 299–305.
Donoso LA, Merryman CF, Shinohara T, et al. S-antigen. Identification of the MAbA9-C6 monoclonal antibody binding site and the uveitopathogenic sites. Curr Eye Res 1986; 5: 995–1004.
Caspi RR, Roberge FG, Nussenblatt RB. Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Science 1987; 237: 1029–32.
Streilein JW, Neiderkorn J. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 1981; 153: 1058–67.
Nussenblatt RB, Rodrigues MM, Wacker WB, et al. Cyclosporin A. Inhibition of experimental autoimmune uveitis in Lewis rats. J Clin Invest 1981; 67: 1228–31.
Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 1983; 96: 275–82.
Nussenblatt RB, Palestine AG, Chan CC, et al. Effectiveness of cyclosporine therapy for Behçet's disease. Arthritis and Rheumatism 1985; 26: 671–9.
Diamond JG, Kaplan HJ. Lensectomy and vitrectomy for complicated cataract secondary to uveitis. Arch Ophthalmol 1978; 96: 1798–804.